The Ukraine crisis – an ethical dilemma for the life Science sector
Russia's inhumane invasion of Ukraine is putting pressure on the life science sector. The major pharmaceutical companies are now pausing clinical studies and other activities in Russia, but exports of pharmaceuticals and medical devices continue, citing patient health as a priority.
Read the full article at biostock.se:
This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/en/